Post-Doc in Artificial Intelligence for Breast Cancer Image Analysis (m­­/­­f­­/­­d)

The Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart (Director: Prof. Dr. M. Schwab) is operated by the Robert Bosch Foundation. Since its foundation in 1973, the institute has emerged as Germany's largest and most renowned scientific research unit in the field of clinical pharmacology. Main research activities concentrate on the influence of genetic, epigenetic, metabolic and non-genetic factors on variability of drug efficacy and their contributions to disease development. The project involves analyzing large-scale histopathology datasets from breast cancer tissue and developing machine learning models for image-based biomarker discovery. This position offers a unique opportunity to work at the intersection of computational pathology, artificial intelligence (AI), and oncology, contributing to clinical cancer research through advanced computer vision applied to exclusive image datasets. We aim to use cancer cell morphology and nuclear features in tissue slides to predict breast cancer (molecular) subtypes, prognosis and treatment response. This work is carried out in close collaboration with our outstanding national and international biomedical partners.